greeksoup/ stock research

Omega Healthcare Investors (OHI) FY2023 results: revenue $950 million, up 8.1% on the year

Omega Healthcare Investors Inc. (OHI) reported revenue of $950 million for fiscal 2023, the year ended 31 December 2023, up 8.1% on the year before. Net income was $242 million, down 43.3%, and diluted earnings per share $1.00. The figures are the company's own, from the 10-K it filed with the SEC on 12 February 2024.

Revenue
$950 million
+8.1% on the year
FY2016FY2023
Operating margin
16.4%
8.9% a year earlier
FY2016FY2023
Net income
$242 million
-43.3% on the year
FY2016FY2023
Diluted EPS
$1.00
-44.4% on the year
FY2016FY2023

this yearthe year beforeHover a bar for its figure.

The year in brief

The four quarters: Q1 FY2023 · Q2 FY2023 · Q3 FY2023 · Q4 FY2023

Income statement (profit and loss)

$ millionFY2023FY2022FY2021On the yearLast 8 years
Revenue9508781,063+8.1%
Operating income15678.6286+98.7%
Operating margin16.4%8.9%26.9%
Interest expense236233235+1.0%
Pre-tax income255436416-41.5%
Income tax6.34.63.8+37.1%
Effective tax rate2.5%1.0%0.9%
Net income242427417-43.3%
Net margin25.5%48.6%39.2%
Diluted EPS$1.00$1.80$1.75-44.4%
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ millionFY2023FY2022FY2021On the yearLast 8 years
Operating cash flow618626722-1.3%
Capital expenditure38.047.244.9-19.5%
Free cash flow580579677+0.2%
Free cash flow margin61.0%65.9%63.7%
Cash from investing-0.8443-524
Cash from financing-473-789-341
Depreciation and amortisation320332342-3.8%
Share-based compensation35.127.321.4+28.4%
Buybacksn/a142n/a
Dividends paid644633638+1.7%
Dividend per share$2.68$2.68$2.680.0%
Diluted shares, weighted250m244m244m+2.5%
Shares outstanding at period end245m234m239m+4.7%

Balance sheet

$ millionFY2023FY2022FY2021On the yearLast 8 years
Shareholders' equity3,5753,6093,907-1.0%
Non-controlling interest188194201-3.2%
Debt5,0675,2875,254-4.2%
Other liabilities288315277-8.7%
Total liabilities and equity9,1179,4059,638-3.1%
Goodwill644643651+0.1%
Intangible assets0.71.41.6-52.8%
Loans1,2121,043n/a+16.2%
Cash and equivalents44329720.5+49.0%
Other assets6,8187,4218,965-8.1%
Total assets9,1179,4059,638-3.1%

10-K for the year ended 31 December 2023, filed 12 February 2024: the filing.